Patient-derived Xenograft (PDX) Modeling of Treatment Response for Triple Negative Breast Cancer
Clinical trial NCT02247037 · COMPLETED
Trial details
- NCT number
- NCT02247037
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2014-07-01
- Primary completion
- 2019-01-22
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.